Peregrine Pharmaceuticals (NASDAQ: PPHM ) surged 39.26% to $1.88 at 9:45 am. Peregrine Pharmaceuticals provided an update from its internal review of discrepancies from its Phase II second-line non-small cell lung cancer (NSCLC) in 121 patients. Dialogic (NASDAQ: DLGC ) shares advanced 31.34% to $2.39. Dialogic shares have dropped